ONTARIO CANCER INSTITUTE

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 3252
 
 
 
C07K PEPTIDES 2134
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 2165
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
6228370 Verotoxin pharmaceutical compositions and medical treatments therewithJul 29, 97May 08, 01[A61K]
5968894 Verotoxin pharmaceutical compositions and medical treatments therewithNov 28, 95Oct 19, 99[A61K, A01N]
5684222 Mutant mouse having a disrupted TNFRp55Jul 12, 94Nov 04, 97[A61K, C12N]
5674977 Branched synthetic peptide conjugateJun 09, 94Oct 07, 97[C07K]
5616491 Knockout miceSep 14, 95Apr 01, 97[C12N]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
7560426 Verotoxin pharmaceutical compositions and medical treatments therewithExpiredMar 12, 07Jul 14, 09[C07K]
7208468 Verotoxin pharmaceutical compositions and medical treatments therewithExpiredNov 12, 04Apr 24, 07[C07K]
6835710 Verotoxin pharmaceutical compositions and medical treatments therewithExpiredAug 03, 00Dec 28, 04[C07K]
6664107 CD45 disrupted nucleic acidExpiredFeb 02, 94Dec 16, 03[C07H, C12N]
6552246 Transgenic mice comprising CD45 knockoutExpiredMay 26, 95Apr 22, 03[A61K, C12N]
6348446 Method for selectively purging CD77+ cells from bone marrow or peripheral bloodExpiredJul 31, 98Feb 19, 02[C07K]
2001/0053,351 Inhibition of GSK-3 betaAbandonedDec 22, 00Dec 20, 01[A61K]
6162627 Methods of identifying inhibitors of sensor histidine kinases through rational drug designExpiredSep 23, 98Dec 19, 00[C12N, C07K]
6077682 Methods of identifying inhibitors of sensor histidine kinases through rational drug designExpiredMar 19, 98Jun 20, 00[C12Q, G01N]
5801145 Method for selectively purging CD77+ cells from bone marrowExpiredFeb 09, 96Sep 01, 98[A61K, C07K]
5731490 Mutant mouse lacking the expression of interferon regulatory factor 1 (IRF-1)ExpiredFeb 21, 95Mar 24, 98[C12N]
5698765 Mouse having a disrupted CD4 geneExpiredMar 06, 95Dec 16, 97[C12N]
5675059 Mouse lacking the expression of interferon regulatory factor 2 (IRF-2)ExpiredSep 08, 93Oct 07, 97[C12N]
5625122 Mouse having a disrupted lck geneExpiredNov 03, 93Apr 29, 97[C12N]
5557032 Knockout miceExpiredMay 26, 95Sep 17, 96[A61K, C12N]
5532158 Interleukin-2 receptor deficient mammalsExpiredOct 21, 94Jul 02, 96[C12N]
5530178 Mutant mouse lacking CD8 surface markerExpiredJul 28, 93Jun 25, 96[C12N]
5223400 Immunoassay method for determining the specificity of binding of a monoclonal antibody to an antigenExpiredJun 01, 89Jun 29, 93[C12Q]
5171850 Intestinal oncofetal geneExpiredAug 31, 88Dec 15, 92[C07H, C12N]
4923799 T cell specific cDNA cloneExpiredNov 09, 87May 08, 90[C12Q, C12N, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.